NO972613D0 - Anvendelse av additiver i kontrastmidler for å forbedre avbildning - Google Patents

Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Info

Publication number
NO972613D0
NO972613D0 NO972613A NO972613A NO972613D0 NO 972613 D0 NO972613 D0 NO 972613D0 NO 972613 A NO972613 A NO 972613A NO 972613 A NO972613 A NO 972613A NO 972613 D0 NO972613 D0 NO 972613D0
Authority
NO
Norway
Prior art keywords
additives
contrast agents
improve imaging
imaging
improve
Prior art date
Application number
NO972613A
Other languages
English (en)
Other versions
NO972613L (no
Inventor
Werner Krause
Ulrich Speck
Wolf-Ruediger Press
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO972613L publication Critical patent/NO972613L/no
Publication of NO972613D0 publication Critical patent/NO972613D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972613A 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning NO972613D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944446694 DE4446694A1 (de) 1994-12-09 1994-12-09 Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung
PCT/EP1995/004826 WO1996017629A1 (de) 1994-12-09 1995-12-08 Verwendung von zusätzen zu kontrastmitteln zur verbesserung der bildgebung

Publications (2)

Publication Number Publication Date
NO972613L NO972613L (no) 1997-06-06
NO972613D0 true NO972613D0 (no) 1997-06-06

Family

ID=6537194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972613A NO972613D0 (no) 1994-12-09 1997-06-06 Anvendelse av additiver i kontrastmidler for å forbedre avbildning

Country Status (6)

Country Link
EP (1) EP0789594A1 (no)
JP (1) JPH10509691A (no)
CA (1) CA2207025A1 (no)
DE (1) DE4446694A1 (no)
NO (1) NO972613D0 (no)
WO (1) WO1996017629A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707081A (pt) * 1996-01-25 1999-05-25 Schering Ag Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal
EP1106177A4 (en) * 1999-06-14 2002-03-13 Toray Industries AGENTS FOR INCREASING MEDICINE ACCUMULATION IN TUMOR TISSUES
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
EP2851097A3 (en) 2002-07-12 2015-06-10 Cook Medical Technologies LLC Drug-coated angioplasty balloons
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450149A (en) * 1981-06-15 1984-05-22 Research Corporation Radiohalogenation method
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
DE4135193C1 (no) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De

Also Published As

Publication number Publication date
CA2207025A1 (en) 1996-06-13
EP0789594A1 (de) 1997-08-20
JPH10509691A (ja) 1998-09-22
NO972613L (no) 1997-06-06
DE4446694A1 (de) 1996-06-13
WO1996017629A1 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
ITMI931611A0 (it) Composizione di gasolio
ID28947A (id) Metode untuk meringankan inkontinensia uriner wanita
DE69506552T2 (de) Seife zusammensetzung
FI964078A0 (fi) Ultraäänen käyttö paperinvalmistuksen yhteydessä
DE69523022D1 (de) Verdickungsmittel enthaltende topische zusammensetzung
BR9509200A (pt) Composição de matéria
FI972623A (fi) Progesteroniantagonisteina ja antiestrogeeneina vaikuttavia yhdisteitä käytettäväksi yhdessä naisilla raskaudenestoon
PT767666E (pt) Metodos e composicoes uteis em profilaxia e em terapia de problemas relacionados com endotoxemia
BR9105087A (pt) Composicao aquosa geleificavel e utilizacao
NO954799D0 (no) Blandinger for å modifisere ballistiske egenskaper
ID18154A (id) Amplop dapat digunakan kembali yang mudah dibuka
NO972613D0 (no) Anvendelse av additiver i kontrastmidler for å forbedre avbildning
HU9203498D0 (en) Inhibition effect of teratogenic agents in embryos
ID25765A (id) Komposisi pembersih kulit
NO933301D0 (no) Mildt vaskepreparat for personlig bruk med forbedret bearbeidbarhet
DE69316417T2 (de) Reduzierung des Stromverbrauches in Mikroprozessoren
FR2751534B1 (fr) Composition pour ameliorer l'hygiene buccale
KR950702235A (ko) 피부 자극성이 낮은 세제 조성물(detergent composition having low skin irritablity)
ID24940A (id) Pemakaian ketolida-ketolida untuk pencegahan komplikasi trombotik arteri mengenai aterosklerosis
AU2541592A (en) Improvements in or relating to modified haptens useful as imaging and therapeutic agents
FI972285A (fi) Kelaattiyhdisteiden käyttö röntgendiagnostisina aineina maksa- ja sappitutkimuksissa
FR2727661B3 (fr) Structure de retroviseur d'automobile pour en eliminer l'humidite
AU1650592A (en) Use of special compounds as smoothing agents in combing oils
EP0467369A3 (en) Use of furosemide to treat allergic conjunctivitis
NO980175D0 (no) Anvendelse av kationiske biopolymerer for å fremstille antiflassmidler